11. Ebola, Rubella AndRabies
-
Upload
mulatumelese -
Category
Documents
-
view
222 -
download
0
Transcript of 11. Ebola, Rubella AndRabies
-
7/29/2019 11. Ebola, Rubella AndRabies
1/37
1
Ebola Virus & MarburgFiloviridae family
The Marburg virus was isolated for the first time in 1967
As a result of three simultaneous outbreaks among laboratory staff inMarburg, Frankfurt, and Belgrade
Ebola: Four strainsEbola-Zaire, Ebola-Sudan, Ebola-
Cote dIvoire, Ebola-Reston
The subtypes of Ebola virus Zaire and Sudan are highly virulent.
Probable reservoir rodent or bat
Common name: Ebola
Both Ebola and Marburg Causes hemorrhagic fever
-
7/29/2019 11. Ebola, Rubella AndRabies
2/37
2
General features
Filoviruses are pleomorphic,
long filamentous thread likeforms with RNA
Coiled RNA in spike-covered
envelope from host cell
Long rods (800-1000 nm) Replication = 8 hours
Therefore, spreads rapidly
-
7/29/2019 11. Ebola, Rubella AndRabies
3/37
3
History
First identified in Sudan
Ebola virus after a
river in Zaire Outbreaks occurred all
over Sudan, Zaire,Congo, Gabon, and theIvory Coast.
Between 1976 and1996, over 1000 deathshave been recorded.
-
7/29/2019 11. Ebola, Rubella AndRabies
4/37
4
Modes of Transmission
There are 3 modes of
infection:
1. Unsterilized needles
2. Suboptimal Hospital
conditions
3. Personal contact
-
7/29/2019 11. Ebola, Rubella AndRabies
5/37
5
Clinical features contd..
Symptoms are abrupt and unexpected.
Incubation between 2 and 21 days
Starts with red eyes, then leads to fever, headache
Flu-like symptoms, fatigue, internal/externalbleeding, massive hemorrhage (uncontrollable
bleeding)
Severe vomiting, Abdominal pain , Diarrhea,Pharyngitis, Conjunctivitis
-
7/29/2019 11. Ebola, Rubella AndRabies
6/37
6
Clinical features contd..
Extremely high body temperature
Impaired liver function
The infected body is also corroding away from theinside.
A cadaver's internal organs have been compared to
black and red tapioca pudding
-
7/29/2019 11. Ebola, Rubella AndRabies
7/37
7
Diagnosis
Viral antigens can be detected by ELISA
Patients
sera may contain virulent virus
Vero, MA-104 cell lines can bee used forcultivation.
PCR can be used for diagnosis.
-
7/29/2019 11. Ebola, Rubella AndRabies
8/37
8
Treatment and Prevention
There is no cure for Ebola
Maintaining renal functionand electrolyte balance and
combating hemorrhage andshock
No vaccine
Due to the extreme biohazard,
doctors must wear Level 4containment suits.
They are the equivalence of aspacesuit.
-
7/29/2019 11. Ebola, Rubella AndRabies
9/37
9
RUBELLA (GERMAN MEASLES)
-
7/29/2019 11. Ebola, Rubella AndRabies
10/37
10
Rubella
From Latin meaning "little red"
Discovered in 18th century - thought to be variant of
measles
First described as distinct clinical entity in Germanliterature
Congenital rubella syndrome (CRS) described byGregg in 1941
-
7/29/2019 11. Ebola, Rubella AndRabies
11/37
11
Rubella Virus
Togavirus
Rubrivirus genus RNA virus
One antigenic type
Rapidly inactivated by chemical agentsultraviolet light, low pH, and heat
-
7/29/2019 11. Ebola, Rubella AndRabies
12/37
12
Rubella Pathogenesis
Respiratory transmission of virus
Replication in nasopharynx and regional lymphnodes
Viremia 5-7 days after exposure with spread totissues
Placenta and fetus infected during viremia
-
7/29/2019 11. Ebola, Rubella AndRabies
13/37
13
Rubella Clinical Features
Incubation period 14 days
(range 12-23 days)
Prodrome of low-grade fever
Maculopapular rash 14-17 days afterexposure
Lymphadenopathy in second week
-
7/29/2019 11. Ebola, Rubella AndRabies
14/37
14
Rash of Rubella
-
7/29/2019 11. Ebola, Rubella AndRabies
15/37
15
Congenital Rubella Syndrome
Infection may affect all organs
May lead to fetal death or premature delivery
Severity of damage to fetus depends ongestational age
Up to 85% of infants affected if infected during
first trimester
-
7/29/2019 11. Ebola, Rubella AndRabies
16/37
16
Congenital Rubella Syndrome
Deafness
Cataracts
Heart defects
Microcephaly
Mental retardation
Bone alterations
Liver and spleen damage
-
7/29/2019 11. Ebola, Rubella AndRabies
17/37
17
Rubella Laboratory Diagnosis
Isolation of rubella virus from clinicalspecimen (e.g., nasopharynx, urine)
Positive serologic test for rubella IgM antibody
Significant rise in rubella IgG by any standard
serologic assay (e.g., enzyme immunoassay)
-
7/29/2019 11. Ebola, Rubella AndRabies
18/37
18
Prevention
Since 1968, a highly effective live attenuatedvaccine has been available with 95%efficacy
Universal vaccination is now offered to allinfants as part of the MMR regimen.
-
7/29/2019 11. Ebola, Rubella AndRabies
19/37
19
Rabies Virus Member of the Lyassavirus of the Rhabdoviridae.
ssRNA enveloped virus, characteristic bullet-shapedappearance with 6-7 nm spike projections.
Virion 130-240nm
-ve stranded RNA codes for 5 proteins
Nucleocapsid (N), polymerase proteins (L, P), matrix (M),
and glycoprotein (G)
Exceedingly wide range of hosts. There are 5 other members of Lyassavirus : Mokola,
Lagosbat, Duvenhage, EBL-1, and EBL-2.
Duvenhage and EBL-2 have been associated with human
rabies.
-
7/29/2019 11. Ebola, Rubella AndRabies
20/37
20
Rabies Virus
Structure of rabies virus
Rabies virus particles
-
7/29/2019 11. Ebola, Rubella AndRabies
21/37
21
Epidemiology
Rabies is a zoonosis which is prevalent in wildlife. The mainanimals involved differs from continent to continent.
Europe fox, bats
Middle East wolf, dog
Asia dog
Africa dog, mongoose, antelope
N America foxes, skunks, raccoons,bats
S America dog, vampire bats
-
7/29/2019 11. Ebola, Rubella AndRabies
22/37
22
Pathogenesis
The commonest mode of transmission in man is by the biteof a rabid animal, usually a dog.
Rabies is an acute infection of the CNS which is almostinvariably fatal
Following inoculation, the virus replicates in the striated orconnective tissue at the site of inoculation
Enters the peripheral nerves through the neuromuscularjunction.
-
7/29/2019 11. Ebola, Rubella AndRabies
23/37
23
Pathogenesis contd
It then spreads to the CNS in the endoneurium ofthe Schwann cells.
Terminally, there is widespread CNS involvement
But few neurons infected with the virus show structural
abnormalities.
The nature of the profound disorder is still notunderstood
Site of bite determine the speed of progression of
clinical manifestation
-
7/29/2019 11. Ebola, Rubella AndRabies
24/37
Clinical Findings
An acute, fulminant, fatal encephalitis The incubation period in humans is typically 12
months
May be as short as 1 week or as long as many years (up to
19 years)
Usually shorter in children than in adults
The clinical spectrum can be divided into three
phases A short prodromal phase
An acute neurologic phase
Coma.
24
-
7/29/2019 11. Ebola, Rubella AndRabies
25/37
Clinical Findings contd..
The prodrome
lasting 210 days
May show any of the following nonspecificsymptoms
Malaise
Anorexia
Headache, photophobia, nausea and vomiting, sorethroat, and fever
Usually there is an abnormal sensation around the
wound site.
25
-
7/29/2019 11. Ebola, Rubella AndRabies
26/37
Clinical Findings contd..
Acute neurologic phase
lasts 27 days
Patients show signs of nervous system dysfunction
Nervousness, apprehension, hallucinations, and bizarrebehavior
General sympathetic over activity is observed, including
lacrimation, pupillary dilatation, and increased salivation
and perspiration A large fraction of patients will exhibit hydrophobia (fear
of water)
The act of swallowing precipitates a painful spasm of the
throat muscles. 26
-
7/29/2019 11. Ebola, Rubella AndRabies
27/37
Clinical Findings contd..
Coma
Convulsive seizures or coma and death
The major cause of death is respiratory paralysis
Paralytic rabies occurs in about 20% of patients, most
frequently in those infected with bat rabies virus
The disease course is slower, with some patients surviving
30 days
Recovery and survival are extremely rare. 27
-
7/29/2019 11. Ebola, Rubella AndRabies
28/37
28
Laboratory Diagnosis
Histopathology - Negri bodies are pathognomonic of rabies.However, Negri bodies are only present in 71% of cases
Rapid virus antigen detection - in recent years, virus antigen
detection by IF had become widely used
Corneal impressions or neck skin biopsy are taken
The Direct Fluorescent Antibody test (DFA) is commonly
used
-
7/29/2019 11. Ebola, Rubella AndRabies
29/37
29
Laboratory Diagnosis
Virus cultivation - The most definitive means ofdiagnosis
From saliva and infected tissue
Cell cultures may be used or more commonly, the specimen is
inoculated intracerebrally into infant mice.
Serology - circulating antibodies appear slowly inthe course of infection
But they are usually present by the time of onset of clinical
symptoms.
-
7/29/2019 11. Ebola, Rubella AndRabies
30/37
30
Negri Body in neuron cell Positive DFA test
Diagnosis of Rabies contd.
-
7/29/2019 11. Ebola, Rubella AndRabies
31/37
31
Treatment and Prevention
Pre-exposure prophylaxis - Inactivated rabies vaccine may beadministered to persons at increased risk
E.g. vets, animal handlers, laboratory workers etc.
Post-exposure prophylaxis - In cases of animal bites, dogs andcats in a rabies endemic area should be held for 10 days forobservation.
If signs develop in the dog or cat, they should be killed and theirtissue examined for diagnosis
-
7/29/2019 11. Ebola, Rubella AndRabies
32/37
32
Treatment and Prevention
Wild animals are not observed but if captured, theanimal should be killed and examined
The essential components of postexposureprophylaxis
The local treatment of wounds and active and passiveimmunization.
Once rabies is established, there is nothing much thatcould be done except intensive supportive care.
-
7/29/2019 11. Ebola, Rubella AndRabies
33/37
33
Postexposure Prophylaxis
Wound treatment - surgical debridement should be carried out
Experimentally, the incidence of rabies in animals can bereduced by local treatment alone.
Passive immunization - human rabies immunoglobulin aroundthe area of the wound; to be supplemented with an I.m. dose toconfer short term protection.
Active immunization - the human diploid cell vaccine (HDCV)is the best preparation available.
The vaccine is usually administered into the deltoid region, and5 doses are usually given.
-
7/29/2019 11. Ebola, Rubella AndRabies
34/37
34
Postexposure Prophylaxis
Combined treatment with rabies immunoglobulin and activeimmunization is much more effective than active immunizationalone
Equine rabies immunoglobulin (ERIG) is available in many
countries and is considerably cheaper than HRIG
-
7/29/2019 11. Ebola, Rubella AndRabies
35/37
35
Rabies VaccinesThe vaccines which are available for humans are presentare inactivated whole virus vaccines.
Nervous Tissue Preparation e.g. Simple Vaccine -
associated with the rare complication ofdemyelinating allergic encephalitis.
Duck Embryo Vaccine - this vaccine strain is grown
in embryonated duck eggs
This vaccine has a lower risk of allergic encephalitis but
is considerably less immunogenic.
-
7/29/2019 11. Ebola, Rubella AndRabies
36/37
36
Rabies Vaccines
Human Diploid Cell Vaccine (HDCV) - this iscurrently the best vaccine available with anefficacy rate of nearly 100%
Rarely any severe reactions. However it is veryexpensive.
Other Cell culture Vaccines - because of the expense ofHDCV, other cell culture vaccines are being developed for
developing countries
However recent data suggests that a much reduced dose ofHDCV given intradermally may be just be effective.
-
7/29/2019 11. Ebola, Rubella AndRabies
37/37
37
Control of Rabies
Urban - canine rabies accounts for more than99% of all human rabies. Control measures
against canine rabies include; stray dog control.
Vaccination of dogs
Quarantine of imported animals
Wildlife - this is much more difficult to controlthan canine rabies.